Optixcare Eye Health (Canada)This page contains information on Optixcare Eye Health for veterinary use.
The information provided typically includes the following:
- Optixcare Eye Health Indications
- Warnings and cautions for Optixcare Eye Health
- Direction and dosage information for Optixcare Eye Health
Optixcare Eye HealthThis treatment applies to the following species:
FOR ANIMAL USE ONLY
OPTIXCARE® EYE HEALTH is a sterile ophthalmic gel, specifically formulated for veterinary use as a topical nutritional antioxidant.
INDICATIONS: For use as an aid in the protection against ocular oxidative stress and oxidative stress linked inflammation which increases with age and can lead to the development of eye issues.
DIRECTIONS FOR USE: Instill 1 to 2 drops onto the corneal surface or conjunctival sac of both eyes 2 to 4 times a day or as recommended by your veterinarian.
INGREDIENTS: Deionized Water, Sorbitol, Carbomer, Resveratrol, Astaxanthin, Ethyl Pyruvate, EGCG,* Disodium EDTA, Cetrimide.
WARNINGS: For veterinary use only. If animal experiences discomfort, or irritation of the eye, discontinue use and consult your veterinarian. The contents are sterile until the cap is removed. To avoid contamination of the tube and contents avoid touching the eye or any other surface with the tip. Recap after use. Discard open tube after 60 days. Store at room temperature.
*Resveratrol is a beneficial antioxidant, found in red grape skins and wine, that has been reported to alleviate oxidative stress and inflammation associated with aging. Astaxanthin is a beneficial antioxidant found in microalgae, salmon and shrimp that is called “super vitamin E” because it has 100-fold higher antioxidant activity than vitamin E. Pyruvate is an endogenous antioxidant that plays an important role in metabolism and the energy-production process and has been shown to be beneficial in reducing oxidative stress and inflammation. Epigallocatechin gallate (EGCG) is found in green tea and not only has 10-fold greater antioxidant activity than vitamin E but also beneficially chelates excess iron to reduce the generation of free radicals.
US Patent No. 9,173,915 | Canadian Patent Application No. TBA | European Patent Application No. 15849725.5 | Japanese Patent Application No. 2017-519236 | Chinese Patent Application No. 20150055062.5
Manufactured for: CLC MEDICA, Ontario, Canada
North American Partner: AVENTIX, Ontario, Canada
20 g/.70 oz.
4350 MAINWAY, BURLINGTON, ON, L7L 5R7
|Every effort has been made to ensure the accuracy of the Optixcare Eye Health information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.|
Copyright © 2021 Animalytix LLC. Updated: 2021-10-04